This inventor holds 1 USPTO granted patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: **Innovative Contributions of Susann Schweiger in Biomedical Research**
Introduction
Susann Schweiger, an accomplished inventor based in Berlin, Germany, has made significant strides in the field of biomedical research. With one patent to her name, her work focuses on innovative methods for treating diseases associated with abnormal levels of microtubule-associated protein phosphatase 2A (PP2Ac). These contributions highlight her commitment to advancing medical science for better healthcare outcomes.
Latest Patents
Her patent, titled "Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated PP2Ac," presents a novel approach to manage conditions linked to abnormal PP2Ac levels. The invention details methods for administering effective amounts of proteins such as MID1 or MID2, as well as specific nucleic acids for treatment. Furthermore, it describes strategies for addressing both elevated and decreased intracellular levels of PP2Ac, providing a comprehensive solution for affected subjects.
Career Highlights
Susann Schweiger is associated with the Max Planck Society for the Advancement of Science, an esteemed institution known for fostering scientific research and innovation. Her position within such a prestigious organization underscores her expertise and dedication to her field. Through her work, she has become recognized for her pioneering research in biochemistry and molecular biology.
Collaborations
In her journey as an inventor, Susann has collaborated with notable colleagues, including Hans-Hilger Ropers and Jennifer Winter. These collaborations have enhanced her research capabilities and have led to groundbreaking advancements in the understanding and treatment of diseases related to protein phosphatase activity.
Conclusion
Susann Schweiger's contributions to biomedical research through her patent exemplify the vital role of inventors in advancing healthcare solutions. Her innovative methods pave the way for future research and potential treatments for diseases linked to microtubule-associated PP2Ac. As the field continues to evolve, her work will undoubtedly inspire further innovations in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile